Cairo – Mubasher: Egyptian International Pharmaceutical Industries (EIPICO) on Tuesday posted a 65.8% year-on-year surge in profits for the first half of 2017 on the back of a growth in sales.

The firm achieved profits of EGP 388.2 million in the six months ended June 2017, up from EGP 234.08 million in the prior-year period, according to a filing to the Egyptian Exchange (EGX).

Revenues rose to EGP 1.2 billion in H1-17 from EGP 962.4 million in the year-ago period.

Meanwhile, standalone profits increased 67.2% to EGP 371.8 million in H1-17 from EGP 222.25 million in H1-16.

EIPICO’s profits amounted to EGP 157.8 million in the three months ended March 2017, compared to EGP 123.01 million in the same period last year.